AstraZeneca

Random entry RSS

Posted in:
Legal

AbbVie Loses Battle to Drop Royalties on Blockbuster Humira®
By Andrew Storaska February 14, 2018 Comments are off
Last week, the Federal Circuit affirmed a lower court’s dismissal of AbbVie’s complaint seeking declaratory judgment of invalidity of...

Read more

Tagged with: AbbVie, adalimumab, AstraZeneca, Federal Circuit, Humira®, Legal, MedImmune

http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
ShareEmail, Linked In, Twitter, Facebook, Google Plus
Posted in:
News

Fujifilm Kyowa Kirin Biologics Announces Application for Humira® (Adalimumab) Biosimilar Accepted by EMA
By C. Nichole Gifford June 8, 2017 Comments are off
Fujifilm Kyowa Kirin Biologics announced that its Medical Marketing Application (“MMA”) for FKB327, a biosimilar to AbbVie’s Humira®...

Read more

Tagged with: AbbVie, adalimumab, AstraZeneca, Avastin®, bevacizumab, EMA, FDA, Fujifilm Kyowa Kirin, Humira®, News, Regulatory

http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
ShareEmail, Linked In, Twitter, Facebook, Google Plus

Back to Top